Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts
-
* Corresponding author: Jonas Bergh Jonas.Bergh@cck.ki.se
1 Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
2 Department of Oncology and Pathology, Radiumhemmet, Karolinska Institutet and University Hospital, Stockholm, Sweden
3 Genentech, San Francisco, California, USA
4 Bristol-Myers Squibb, Princeton, New Jersey, USA
5 Regional Oncological Center, Uppsala University Hospital, Uppsala, Sweden
6 Genome Institute of Singapore, Singapore
7 Department of Pathology, Uppsala University Hospital, Uppsala, Sweden
8 Department of Surgery Sciences, Karolinska Institutet and Hospital, Stockholm, Sweden
Breast Cancer Research 2005, 7:R953-R964 doi:10.1186/bcr1325
Published: 3 October 2005Additional files
Additional file 1:
Supplementary Report presenting (i) details of gene filtering, (ii) details of cross-validation procedure to choose 64-gene signature, (iii) list of 64 genes, and (iv) other statistical analyses based on secondary endpoints.
Format: DOC Size: 186KB Download file
This file can be viewed with: Microsoft Word Viewer
